Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Net Equity Issued and Repurchased (2021 - 2026)

Valneva SE (VALN) posted Net Equity Issued and Repurchased of $48986.6 for Q3 2023, up 149.44% sequentially from -$99092.1 in Q2 2023, and up 115.67% YoY from $22713.4 in Q3 2022.

Analysis

Valneva SE (VALN) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

Valneva SE has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at $48986.6 in Q3 2023.

  • Quarterly Net Equity Issued and Repurchased rose 115.67% year-over-year to $48986.6 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $97.5 million (down 49.68% YoY) and the FY2022 annual result came in at $200.1 million, up 1.48% from the prior year.
  • Net Equity Issued and Repurchased climbed to $48986.6 in Q3 2023 per VALN's latest filing, from -$99092.1 in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $99.9 million in Q2 2021 and troughed at -$312565.0 in Q3 2022.
  • A 3-year average of $35.8 million and a median of $2.7 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
  • The sharpest annual moves came in 2022 and 2023: Net Equity Issued and Repurchased sank 128.49% in 2022, then surged 115.67% in 2023.
  • Over 3 years, Net Equity Issued and Repurchased stood at $93.3 million in 2021, then increased by 4.81% to $97.8 million in 2022, then plunged by 99.95% to $48986.6 in 2023.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $48986.6, -$99092.1, and -$208228.3 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 39.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.96 Mn
Mar 31, 2026 1.08 Mn
Dec 31, 2025 4.37 Mn
Sep 30, 2025 7.15 Mn
Jun 30, 2025 22.79 Mn
Dec 31, 2024 -343,019.12
Sep 30, 2024 63.10 Mn
Sep 30, 2023 309.99 Mn
Jun 30, 2023 -310.13 Mn
Mar 31, 2023 -208,228.31
Dec 31, 2022 97.78 Mn
Sep 30, 2022 -312,565.04
Jun 30, 2022 96.66 Mn
Mar 31, 2022 4.18 Mn
Dec 31, 2021 93.29 Mn
Sep 30, 2021 -136,797.33